The Peptide Promise With NervGen's Mike Kelly
Business Of Biotech
Peptides and Neurodegenerative Advances
This chapter examines the evolution and current advancements of peptides in treating neurodegenerative diseases, focusing on therapies for conditions like ALS and Alzheimer’s. It highlights innovative strategies, particularly the use of peptides like NVG291 to enhance nerve repair, and discusses future developments in neurotherapeutics.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
